Yeon Ju Kyung

Yeon Ju Kyung

Auto-generated profile, based on publicly available information

Yeon Ju Kyung

Cancer Biology and Genetics Program, Memorial Sloan Kettering Cancer Center, New York, New York

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 April 2021 in Science
Verified
Journal Article
Closed access
PDF file
JZJiajun Zhu
Jiajun Zhu
SSSimon Schwörer
Simon Schwörer
MBMirela Berisa
Mirela Berisa
YKYeon Ju Kyung
Yeon Ju Kyung
KRKeun Woo Ryu
Keun Woo Ryu
CTCraig B. Thompson
Craig B. Thompson
Providing for protein synthesis: Compartmentalization of metabolic processes into organelles can have important consequences. Zhu et al. examined the role of the coenzyme nicotinamide adenine dinucleotide phosphate (NADP + ) and its reduced form (NADPH) in cultured human cells. They found that cells lacking NAD kinase 2, an enzyme needed to make NADPH, had decreased abundance of mitochondrial NADPH and proliferated slowly in culture medium with limited nutrients because of a lack of proline. Proline is made in the mitochondria, and thus a key function of NADPH in the mitochondria appears to be the synthesis of proline to sustain cellular protein synthesis. Science , abd5491, this issue p. 968

22 July 2022 in Cancer Research
Verified
Journal Article
Open access
PDF file
ABAgata A. Bielska
Agata A. Bielska
CHCaitlin F. Harrigan
Caitlin F. Harrigan
YKYeon Ju Kyung
Yeon Ju Kyung
QMQuaid Morris
Quaid Morris
WPWilhelm Palm
Wilhelm Palm
CTCraig B. Thompson
Craig B. Thompson
The mTOR is a key regulator of cell growth that integrates growth factor signaling and nutrient availability and is a downstream effector of oncogenic receptor tyrosine kinases (RTK) and PI3K/Akt signaling. Thus, activating mTOR mutations would be expected to enhance growth in many tumor types. However, tumor sequencing data have shown that mTOR mutations are enriched only in renal clear cell carcinoma, a clinically hypervascular tumor unlikely to be constrained by nutrient availability. To further define this cancer-type–specific restriction, we studied activating mutations in mTOR. All mTOR mutants tested enhanced growth in a cell-type agnostic manner under nutrient-replete conditions but were detrimental to cell survival in nutrient-poor conditions. Consistently, analysis of tumor data demonstrated that oncogenic mutations in the nutrient-sensing arm of the mTOR pathway display a similar phenotype and were exceedingly rare in human cancers of all types. Together, these data suggest that maintaining the ability to turn off mTOR signaling in response to changing nutrient availability is retained in most naturally occurring tumors. Significance: This study suggests that cells need to inactivate mTOR to survive nutrient stress, which could explain the rarity of mTOR mutations and the limited clinical activity of mTOR inhibitors in cancer.

31 March 2023
Verified
Other
Open access
ABAgata A. Bielska
Agata A. Bielska
CHCaitlin F. Harrigan
Caitlin F. Harrigan
YKYeon Ju Kyung
Yeon Ju Kyung
QMQuaid Morris
Quaid Morris
WPWilhelm Palm
Wilhelm Palm
CTCraig B. Thompson
Craig B. Thompson
Supplementary Figure from Activating mTOR Mutations Are Detrimental in Nutrient-Poor Conditions

31 March 2023
Verified
Other
Open access
ABAgata A. Bielska
Agata A. Bielska
CHCaitlin F. Harrigan
Caitlin F. Harrigan
YKYeon Ju Kyung
Yeon Ju Kyung
QMQuaid Morris
Quaid Morris
WPWilhelm Palm
Wilhelm Palm
CTCraig B. Thompson
Craig B. Thompson
Supplementary Figure from Activating mTOR Mutations Are Detrimental in Nutrient-Poor Conditions

31 March 2023
Verified
Other
Open access
ABAgata A. Bielska
Agata A. Bielska
CHCaitlin F. Harrigan
Caitlin F. Harrigan
YKYeon Ju Kyung
Yeon Ju Kyung
QMQuaid Morris
Quaid Morris
WPWilhelm Palm
Wilhelm Palm
CTCraig B. Thompson
Craig B. Thompson
Supplementary Figure from Activating mTOR Mutations Are Detrimental in Nutrient-Poor Conditions

31 March 2023
Verified
Other
Open access
ABAgata A. Bielska
Agata A. Bielska
CHCaitlin F. Harrigan
Caitlin F. Harrigan
YKYeon Ju Kyung
Yeon Ju Kyung
QMQuaid Morris
Quaid Morris
WPWilhelm Palm
Wilhelm Palm
CTCraig B. Thompson
Craig B. Thompson
Supplementary Data from Activating mTOR Mutations Are Detrimental in Nutrient-Poor Conditions